C-terminal fragment of N-cadherin accelerates synapse destabilization by amyloid-β

Brain

Volumn 135, Issue 7, 2012, Pages 2140-2154

  Andreyeva, Aksana ^a   Nieweg, Katja ^a   Horstmann, Katharina ^a   Klapper, Simon ^a   Müller Schiffmann, Andreas ^a   Korth, Carsten ^a   Gottmann, Kurt ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; Amyloid peptide; Glutamatergic synapses; N cadherin; secretase

Indexed keywords

AMPA RECEPTOR; AMYLOID BETA PROTEIN; CATENIN; GAMMA SECRETASE; NERVE CELL ADHESION MOLECULE; PRESENILIN 1;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVITY; EXCITATION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYNAPSE; WESTERN BLOTTING;

EID: 84863200508     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws120     Document Type: Article

References (69)

1. Arrikath J, Reichardt LF. Cadherins and catenins at synapses: roles in synaptogenesis and synaptic plasticity. Trends Neurosci 2008; 31: 487-94.
2. Bamji SX, Shimazu K, Kimes N, Huelsken J, Birchmeier W, Lu B, et al. Role of b-catenin in synaptic vesicle localization and presynaptic assembly. Neuron 2003; 40: 719-31. (Pubitemid 37431033)
3. Benson DL, Tanaka H. N-cadherin redistribution during synaptogenesis in hippocampal neurons. J Neurosci 1998; 18: 6892-904. (Pubitemid 28388019)
4. Bentahir M, Nyabi O, Verhamme J, Tolia A, Horre K, Wiltfang J, et al. Presenilin clinical mutations can affect γ-secretase activity by different mechanisms. J Neurochem 2006; 96: 732-42.
5. Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA, et al. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 1997; 19: 939-45. (Pubitemid 27471397)
6. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/Aβ1-40 ratio in vitro and in vivo. Neuron 1996; 17: 1005-13. (Pubitemid 26424026)
7. Bozdagi O, Valcin M, Poskanzer K, Tanaka H, Benson DL. Temporally distinct demands for classic cadherins in synapse formation and maturation. Mol Cell Neurosci 2004; 27: 509-21. (Pubitemid 39540004)
8. Bozdagi O, Wang XB, Nikitczuk JS, Anderson TR, Bloss EB, Radice GL, et al. Persistence of coordinated long-term potentiation and dendritic spine enlargement at mature hippocampal CA1 synapses requires N-cadherin. J Neurosci 2010; 30: 9984-9.
9. Buttini M, Masliah E, Barbour R, Grajeda H, Motter R, Johnson-Wood K, et al. Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease. J Neurosci 2005; 25: 9096-101. (Pubitemid 41500817)
10. Chang EH, Savage MJ, Flood DG, Thomas JM, Levy RB, Mahadomrongkul V, et al. AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice. Proc Natl Acad Sci USA 2006; 103: 3410-15. (Pubitemid 43346482)
11. De Strooper B. Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease. EMBO Rep 2007; 8: 141-6. (Pubitemid 46420841)
12. De Strooper B. Proteases and proteolysis in Alzheimer's disease: a multi-factorial view on the disease process. Physiol Rev 2010; 90: 465-94.
13. Dewachter I, Filipkowski RK, Priller C, Ris L, Neyton J, Croes S, et al. Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice. Neurobiol Aging 2009; 30: 241-56.
14. Elste AM, Benson DL. Structural basis for developmentally regulated changes in cadherin function at synapses. J Comp Neurol 2006; 495: 324-35. (Pubitemid 43271476)
15. Evans NA, Facci L, Owen DE, Soden PE, Burbidge SA, Prinjha RK, et al. Ab1-42 reduces synapse number and inhibits neurite outgrowth in primary cortical and hippocampal neurons: a quantitative study. J Neurosci Meth 2008; 175: 96-103.
16. Georgakopoulos A, Marambaud P, Efthimiopoulos S, Shioi J, Cui W, Li HC, et al. Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts. Mol Cell 1999; 4: 893-902. (Pubitemid 30054896)
17. Gottmann K. Transsynaptic modulation of the synaptic vesicle cycle by cell-adhesion molecules. J Neurosci Res 2008; 86: 223-32. (Pubitemid 351196728)
18. Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid b-peptide. Nat Rev Mol Cell Biol 2007; 8: 101-12. (Pubitemid 46432529)
19. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-6. (Pubitemid 34790756)
20. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, et al. AMPAR removal underlies Ab-induced synaptic depression and dendritic spine loss. Neuron 2006; 52: 831-43. (Pubitemid 44828454)
21. Jüngling K, Eulenburg V, Moore R, Kemler R, Lessmann V, Gottmann K. N-cadherin transsynaptically regulates short-term plasticity at glutamatergic synapses in embryonic stem cell-derived neurons. J Neurosci 2006; 26: 6968-78. (Pubitemid 44309864)
22. Jüngling K, Nägler K, Pfrieger FW, Gottmann K. Purification of embryonic stem cell-derived neurons by immunoisolation. FASEB J 2003; 17: 2100-2.
23. Kelly BL, Ferreira A. Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons. Neuroscience 2007; 147: 60-70. (Pubitemid 46876699)
24. Knobloch M, Mansuy IM. Dendritic spine loss and synaptic alterations in Alzheimer's disease. Mol Neurobiol 2008; 37: 73-82.
25. Koffie RM, Meyer-Luehmann M, Hashimoto T, Adams KW, Mielke ML, Garcia-Alloza M, et al. Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci USA 2009; 106: 4012-7.
26. Kwiatkowski AV, Weis WI, Nelson WJ. Catenins: playing both sides of the synapse. Curr Opin Cell Biol 2007; 19: 551-6. (Pubitemid 350016851)
27. Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D. Soluble oligomers of amyloid β protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 2009a; 62: 788-801.
28. Li XJ, Zhang X, Johnson MA, Wang ZB, Lavaute T, Zhang SC. Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells. Development 2009b; 136: 4055-63.
29. Malinverno M, Carta M, Epis R, Marcello E, Verpelli C, Cattabeni F, et al. Synaptic localization and activity of ADAM10 regulate excitatory synapses through N-cadherin cleavage. J Neurosci 2010; 30: 16343-55.
30. Marambaud P, Wen PH, Dutt A, Shioi J, Takashima A, Siman R, et al. A CBP binding transcriptional repressor produced by the PS1/ε-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Cell 2003; 114: 635-45. (Pubitemid 37159259)
31. Moehlmann T, Winkler E, Xia X, Edbauer D, Murrell J, Capell A, et al. Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Ab42 production. Proc Natl Acad Sci USA 2002; 99: 8025-30. (Pubitemid 34650999)
32. Mohrmann R, Lessmann V, Gottmann K. Developmental maturation of synaptic vesicle cycling as a distinctive feature of central glutamatergic synapses. Neuroscience 2003; 117: 7-18. (Pubitemid 36246498)
33. Mohrmann R, Werner M, Hatt H, Gottmann K. Target-specific factors regulate the formation of glutamatergic transmitter release sites in cultured neocortical neurons. J Neurosci 1999; 19: 10004-13. (Pubitemid 30226672)
34. Müller-Schiffmann A, Marz-Berberich J, Andreyeva A, Ronicke R, Bartnik D, Brener O, et al. Combining independent drug classes into superior, synergistically acting hybrid molecules. Angew Chem Int Ed 2010; 49: 8743-6.
35. Murase S, Moser E, Schuman EM. Depolarization drives beta-Catenin into neuronal spines promoting changes in synaptic structure and function. Neuron 2002; 35: 91-105. (Pubitemid 34804325)
36. Nieman MT, Kim J-B, Johnson KR, Wheelock MJ. Mechanism of extracellular domain-deleted dominant negative cadherins. J Cell Sci 1999; 112: 1621-32. (Pubitemid 29261323)
37. Nimmrich V, Grimm C, Draguhn A, Barghorn S, Lehmann A, Schoemaker H, et al. Amyloid β oligomers (Aβ1-42 globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium channels. J Neurosci 2008; 28: 788-97. (Pubitemid 351159014)
38. Palop JJ, Mucke L. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses towards neural networks. Nat Neurosci 2010; 13: 812-8.
39. Panza F, Frisardi V, Imbimbo BP, Capurso C, Logroscino G, Sancarlo D, et al. γ-Secretase inhibitors for the treatment of Alzheimer's disease: the current state. CNS Neurosci Ther 2010; 16: 272-84.
40. Parodi J, Sepulveda FJ, Roa J, Opazo C, Inestrosa NC, Aguayo LG. Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure. J Biol Chem 2010; 285: 2506-14.
41. Podlisny MB, Ostaszewski BL, Squazzo SL, Koo EH, Rydell RE, Teplow DB, et al. Aggregation of secreted amyloid beta-protein into sodium dodecyl sulphate-stable oligomers in cell culture. J Biol Chem 1995; 270: 9564-70.
42. Priller C, Mitteregger G, Paluch S, Vassallo N, Staufenbiel M, Kretzschmar HA, et al. Excitatory synaptic transmission is depressed in cultured hippocampal neurons of APP/PS1 mice. Neurobiol Aging 2009; 30: 1227-38.
43. Reiss K, Maretzky T, Ludwig A, Tousseyn T, de Strooper B, Hartmann D, et al. ADAM 10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling. EMBO J 2005; 24: 742-52. (Pubitemid 40396104)
44. Riehl R, Johnson K, Bradley R, Grunwald GB, Cornel E, Lilienbaum A, et al. Cadherin function is required for axon outgrowth in retinal ganglion cells in vivo. Neuron 1996; 17: 837-48. (Pubitemid 26424012)
45. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science 2002; 298: 789-91. (Pubitemid 35231524)
46. Selkoe DJ, Wolfe MS. Presenilin: running with scissors in the membrane. Cell 2007; 131: 215-21. (Pubitemid 47576152)
47. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 2007; 27: 2866-75. (Pubitemid 46438992)
48. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 2008; 14: 837-842.
49. Shen J, Kelleher RJ III. The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism. Proc Natl Acad Sci USA 2007; 104: 403-9. (Pubitemid 46123039)
50. Shen K, Scheiffele P. Genetics and cell biology of building specific synaptic connectivity. Annu Rev Neurosci 2010; 33: 473-507.
51. Slezak M, Pfrieger FW. New roles for astrocytes: regulation of CNS synaptogenesis. Trends Neurosci 2003; 26: 531-5. (Pubitemid 37176907)
52. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, et al. Regulation of NMDA receptor trafficking by amyloid-β. Nat Neurosci 2005; 8: 1051-8. (Pubitemid 41061516)
53. Stan A, Pielarski KN, Brigadski T, Wittenmayer N, Fedorchenko O, Gohla A, et al. Essential cooperation of N-cadherin and neuroligin-1 in the transsynaptic control of vesicle accumulation. Proc Natl Acad Sci USA 2010; 107: 11116-21.
54. Südhof TC. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008; 455: 903-11.
55. Tai C-Y, Kim SA, Schuman EM. Cadherins and synaptic plasticity. Curr Opin Cell Biol 2008; 20: 567-75.
56. Tai C-Y, Mysore SP, Chiu C, Schuman EM. Activity-regulated N-cadherin endocytosis. Neuron 2007; 54: 771-85. (Pubitemid 46843522)
57. Takeichi M. The cadherin superfamily in neuronal connections and interactions. Nat Rev Neurosci 2007; 8: 11-20. (Pubitemid 46011995)
58. Tang L, Hung CP, Schuman EM. A role for the cadherin family of cell adhesion molecules in hippocampal long-term potentiation. Neuron 1998; 20: 1165-75. (Pubitemid 28293133)
59. Terry RD, Masliah E, Salmon DP, Butters N, De Teresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30: 572-80.
60. Ting JT, Kelley BG, Lambert TJ, Cook DG, Sullivan JM. Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms. Proc Natl Acad Sci USA 2007; 104: 353-8. (Pubitemid 46068035)
61. Togashi H, Abe K, Mizoguchi A, Takaoka K, Chisaka O, Takeichi M. Cadherin regulates dendritic spine morphogenesis. Neuron 2002; 35: 77-89. (Pubitemid 34804324)
62. Uemura K, Kihara T, Kuzuya A, Okawa K, Nishimoto T, Ninomiya H, et al. Characterization of sequential N-cadherin cleavage by ADAM10 and PS1. Neurosci Lett 2006; 402: 278-83. (Pubitemid 43850164)
63. Vitureira N, Letellier M, White IJ, Goda Y. Differential control of presynaptic efficacy by postsynaptic N-cadherin and beta-catenin. Nat Neurosci 2011; 15: 81-9.
64. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002; 416: 535-9. (Pubitemid 34288854)
65. Walsh DM, Selkoe DJ. Aβ Oligomers - a decade of discovery. J Neurochem 2007; 101: 1172-84.
66. Williams EJ, Williams G, Gour B, Blaschuk O, Doherty P. INP, a novel N-cadherin antagonist targeted to the amino acids that flank the HAV motif. Mol Cell Neurosci 2000; 15: 456-64. (Pubitemid 30395370)
67. Zaehres H, Kögler G, Arauzo-Bravo MJ, Bleidissel M, Santourlidis S, Weinhold S, et al. Induction of pluripotency in human cord blood unrestricted somatic stem cells. Exp Haematol 2010; 38: 809-18.
68. Zhang C, Wu B, Beglopoulos V, Wines-Samuelson M, Zhang D, Dragatsis I, et al. Presenilins are essential for regulating neurotransmitter release. Nature 2009; 460: 632-6.
69. Zhang D, Zhang C, Ho A, Kirkwood A, Südhof TC, Shen J. Inactivation of presenilins causes pre-synaptic impairment prior to post-synaptic dysfunction. J Neurochem 2010; 115: 1215-21.